General Information of the Compound
| Compound ID |
CP0382627
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3R,5S)-N,1-dibenzyl-3,5-dimethyl-2-oxo-3,5-dihydro-1,4-benzodiazepine-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H27N3O2
|
||||||||||||||||||
| Molecular Weight |
413.521
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1N([C@H](C)C(=O)N(Cc2ccccc2)c2ccccc12)C(=O)NCc1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H27N3O2/c1-19-23-15-9-10-16-24(23)28(18-22-13-7-4-8-14-22)25(30)20(2)29(19)26(31)27-17-21-11-5-3-6-12-21/h3-16,19-20H,17-18H2,1-2H3,(H,27,31)/t19-,20+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XWSPLWBSYSPPFJ-VQTJNVASSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03095, Voltage-dependent T-type calcium channel subunit alpha-1G
Protein ID: PT04557, Voltage-dependent T-type calcium channel subunit alpha-1H
Protein ID: PT02881, Voltage-dependent T-type calcium channel subunit alpha-1I